Learn More
OBJECTIVES To compare the effectiveness and safety of rituximab alone or in combination with either methotrexate or leflunomide. METHODS 10 European registries submitted anonymised datasets with(More)
OBJECTIVE To assess the 6-month effectiveness of the first rituximab (RTX) course in rheumatoid arthritis (RA) and to identify possible predictors of response. METHOD 10 European registries(More)
OBJECTIVES To update the evidence for the efficacy of biological disease-modifying antirheumatic drugs (bDMARDs) in patients with rheumatoid arthritis (RA) to inform European League Against(More)